These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2785212)
1. Synthesis of the 2-chloro analogues of 3'-deoxyadenosine, 2',3'-dideoxyadenosine, and 2',3'-didehydro-2',3'-dideoxyadenosine as potential antiviral agents. Rosowsky A; Solan VC; Sodroski JG; Ruprecht RM J Med Chem; 1989 May; 32(5):1135-40. PubMed ID: 2785212 [TBL] [Abstract][Full Text] [Related]
2. Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside. Pauwels R; Baba M; Balzarini J; Herdewijn P; Desmyter J; Robins MJ; Zou RM; Madej D; De Clercq E Biochem Pharmacol; 1988 Apr; 37(7):1317-25. PubMed ID: 3258516 [TBL] [Abstract][Full Text] [Related]
3. The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Balzarini J; Pauwels R; Baba M; Robins MJ; Zou RM; Herdewijn P; De Clercq E Biochem Biophys Res Commun; 1987 May; 145(1):269-76. PubMed ID: 3496089 [TBL] [Abstract][Full Text] [Related]
4. Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus. Balzarini J; Baba M; Pauwels R; Herdewijn P; Wood SG; Robins MJ; de Clercq E Mol Pharmacol; 1988 Mar; 33(3):243-9. PubMed ID: 3258404 [TBL] [Abstract][Full Text] [Related]
5. The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication. Balzarini J; Robins MJ; Zou RM; Herdewijn P; De Clercq E Biochem Biophys Res Commun; 1987 May; 145(1):277-83. PubMed ID: 3496090 [TBL] [Abstract][Full Text] [Related]
6. Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-2',3'-dideoxyadenosine derivatives. Haertle T; Carrera CJ; Wasson DB; Sowers LC; Richman DD; Carson DA J Biol Chem; 1988 Apr; 263(12):5870-5. PubMed ID: 3258602 [TBL] [Abstract][Full Text] [Related]
7. Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities. Mullah KB; Rao TS; Balzarini J; De Clercq E; Bentrude WG J Med Chem; 1992 Jul; 35(15):2728-35. PubMed ID: 1495007 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis. Herdewijn P; Pauwels R; Baba M; Balzarini J; De Clercq E J Med Chem; 1987 Nov; 30(11):2131-7. PubMed ID: 3499515 [TBL] [Abstract][Full Text] [Related]
9. Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine. Ahluwalia GS; Cooney DA; Shirasaka T; Mitsuya H; Driscoll JS; Johns DG Mol Pharmacol; 1994 Nov; 46(5):1002-8. PubMed ID: 7969062 [TBL] [Abstract][Full Text] [Related]
10. Nucleic acid related compounds. 84. Synthesis of 6'-(E and Z)-halohomovinyl derivatives of adenosine, inactivation of S-adenosyl-L-homocysteine hydrolase, and correlation of anticancer and antiviral potencies with enzyme inhibition. Wnuk SF; Yuan CS; Borchardt RT; Balzarini J; De Clercq E; Robins MJ J Med Chem; 1994 Oct; 37(21):3579-87. PubMed ID: 7932585 [TBL] [Abstract][Full Text] [Related]
11. Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes. Carson DA; Haertle T; Wasson DB; Richman DD Biochem Biophys Res Commun; 1988 Mar; 151(2):788-93. PubMed ID: 3258154 [TBL] [Abstract][Full Text] [Related]
12. Metabolic pathways for the activation of the antiretroviral agent 2',3'-dideoxyadenosine in human lymphoid cells. Johnson MA; Ahluwalia G; Connelly MC; Cooney DA; Broder S; Johns DG; Fridland A J Biol Chem; 1988 Oct; 263(30):15354-7. PubMed ID: 3262616 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of human immunodeficiency virus (HIV) by 3'-azido-2', 3'-dideoxyguanosine in vitro. Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E Biochem Biophys Res Commun; 1987 Jun; 145(3):1080-6. PubMed ID: 3649230 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 6-substituted 2',3'-dideoxypurine nucleosides as potential anti-human immunodeficiency virus agents. Chu CK; Ullas GV; Jeong LS; Ahn SK; Doboszewski B; Lin ZX; Beach JW; Schinazi RF J Med Chem; 1990 Jun; 33(6):1553-61. PubMed ID: 2342052 [TBL] [Abstract][Full Text] [Related]
15. Permeation and salvage of dideoxyadenosine in mammalian cells. Plagemann PG; Woffendin C Mol Pharmacol; 1989 Jul; 36(1):185-92. PubMed ID: 2787472 [TBL] [Abstract][Full Text] [Related]
16. Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. Balzarini J; Kruining J; Wedgwood O; Pannecouque C; Aquaro S; Perno CF; Naesens L; Witvrouw M; Heijtink R; De Clercq E; McGuigan C FEBS Lett; 1997 Jun; 410(2-3):324-8. PubMed ID: 9237655 [TBL] [Abstract][Full Text] [Related]
17. Enhanced stimulation by ribavirin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of purine 2'-beta-fluoro-2',3'-dideoxynucleosides. Johns DG; Ahluwalia GS; Cooney DA; Mitsuya H; Driscoll JS Mol Pharmacol; 1993 Sep; 44(3):519-23. PubMed ID: 8371712 [TBL] [Abstract][Full Text] [Related]
18. Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV. Gudmundsson KS; Daluge SM; Johnson LC; Jansen R; Hazen R; Condreay LD; McGuigan C Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1953-61. PubMed ID: 14609234 [TBL] [Abstract][Full Text] [Related]
19. Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2'-beta-fluoro-2',3'-dideoxyadenosine in peripheral blood mononuclear cells. Gao WY; Mitsuya H; Driscoll JS; Johns DG Biochem Pharmacol; 1995 Jul; 50(2):274-6. PubMed ID: 7632173 [TBL] [Abstract][Full Text] [Related]
20. 2'-Fluoro-2',3'-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2',3'-dideoxyadenosine. Masood R; Ahluwalia GS; Cooney DA; Fridland A; Marquez VE; Driscoll JS; Hao Z; Mitsuya H; Perno CF; Broder S Mol Pharmacol; 1990 Apr; 37(4):590-6. PubMed ID: 2109183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]